The global companion animal health market is expected to grow from USD 122.94 billion 2017 to USD 169.67 billion by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 4.71%.

"Increasing initiatives by government and animal welfare associations
is one of the factors largely attributing to the growth of companion animal health market globally"

The factors attributing to the growth of the market are increasing initiatives by government and animal welfare associations, technological advancements in the field of animal healthcare, changing perception of the consumers toward pet health and longer life expectancy for companion animal, increasing disposable incomes and pet owners afford to spend more on pet healthcare, and increasing online shopping and home delivery is driving the product sale. However, some factors such as increase in cheap counterfeit drugs, and lack of infrastructure, funding, and standardization may hinder the market growth. The global companion animal health market is expected to showcase the opportunities such as increase in cheap counterfeit drugs, and lack of infrastructure, funding, and standardization. In the near future, the market may face the possible challenges in the growth due to prohibition on use of antibiotics and antimicrobials in animal feed in many countries,, and high cost associated with animal testing and veterinary in developing countries. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the global companion animal health market market.

On the basis of animal, the global companion animal health market is studied across Cats, Dogs, and Horses.

On the basis of indication, the global companion animal health market is studied across Behavioral Disorders, Dental Diseases, Dermatologic Diseases, Infectious Diseases, and Orthopedic Diseases.

On the basis of type, the global companion animal health market is studied across Medicinal Additive Feed, Nutritional Feed Additives, Pharmaceuticals, and Vaccines.

On the basis of end user, the global companion animal health market is studied across Retail Pharmacies and Veterinary Hospitals.

On the basis of geography, the global companion animal health market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).

"Aratana Therapeutics, Inc.: The potential growing player for the global companion animal health market"

The key players profiled in the global companion animal health market are Aratana Therapeutics, Inc., Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale S.A., Dechra Pharmaceuticals PLC, Elanco US, Inc., Eli Lilly and Company, Merck & Co., Inc., Nutreco N.V., Vetoquinol SA, Virbac SA, and Zoetis, Inc..


The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global companion animal health market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global companion animal health market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global companion animal health market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global companion animal health market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global companion animal health market.